MRP4 Antibodies

Santa Cruz Biotechnology offers a broad range of MRP4 monoclonal antibodies for research focused on understanding Multidrug Resistance Protein 4 (MRP4). MRP4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MRP4 is an essential member of the ATP-binding cassette (ABC) transporter family, facilitating the efflux of various substrates, including drugs and signaling molecules, across cellular membranes. The role of MRP4 in pharmacokinetics and drug resistance makes it a key target for cancer therapy research and studies of other diseases. Understanding MRP4 expression and regulation can reveal new therapeutic strategies and support drug development efforts. Researchers can utilize MRP4 monoclonal antibodies to investigate cellular transport mechanisms and their impact on drug resistance. Advanced research techniques supported by MRP4 monoclonal antibodies enable detailed analysis of protein localization and expression patterns. Santa Cruz Biotechnology monoclonal antibodies for MRP4 research support scientists worldwide in advancing our understanding of drug resistance and cellular transport mechanisms.